Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers

Clinical Microbiology and Infection

Volumn 12, Issue 2, 2006, Pages 186-189

  Tentolouris, N ^a,b   Petrikkos, G ^a   Vallianou, N ^a   Zachos, C ^a   Daikos, G L ^a   Tsapogas, P ^a   Markou, G ^a   Katsilambros, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Diabetes; Foot ulcers; Infection; Methicillin resistance; MRSA; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CITROBACTER; CLINICAL PROTOCOL; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DISEASE PREDISPOSITION; DRUG USE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FOOT ULCER; HOSPITALIZATION; HUMAN; INFORMED CONSENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SERRATIA MARCESCENS; STREPTOCOCCUS AGALACTIAE;

BACTERIA (MICROORGANISMS); CITROBACTER; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; POSIBACTERIA; PROTEUS (ENTEROBACTERIA); PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE;

EID: 33644908513     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01279.x     Document Type: Article

References (18)

1. Reiber G, Lipsky B, Gibbons G. The burden of diabetic foot ulcers. Am J Surg 1998; 176 (suppl. 2A): 5-10.
2. Tentolouris N, Jude E, Smirnof I, Knowles E, Boulton AJM. Methicillin-resistant Staphylococcus aureus: An increasing problem in a diabetic foot clinic. Diabet Med 1999; 16: 767-771.
3. Game F, Jeffcoate W. MRSA and osteomyelitis of the foot in diabetes. Diabet Med 2004; 21 (suppl 4): 16-19.
4. Hartemann-Heurtier A, Robert J, Jacqueminet S et al. Diabetic foot ulcer and multidrug-resistant organisms: Risk factors and impact. Diabet Med 2004; 21: 710-715.
5. Dang C, Prasad YD, Boulton AJM, Jude E. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: A worsening problem. Diabet Med 2003; 20: 159-161.
6. Lipsky BA, Berendt AR, Embil J, De Lalla F. Diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2004; 20 (suppl 1): 56-64.
7. Abbott CA, Vileikyte L, Williamson SH, Carrington A, Boulton AJM. Multicenter study of the incidence and preventive risk factors for diabetic foot ulceration. Diabetes Care 1998; 21: 1071-1075.
8. Wagner FW. Algorithms of diabetic foot care. In: Levin ME, O'Neal LW, eds. The diabetic foot, 2nd edn. St Louis: Mosby Yearbook, 1983; 201-232.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
10. Martineau F, Picard FJ, Lansac N et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 2000; 44: 231-238.
11. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003; 37: 1453-1460.
12. Eguia JM, Chambers HF. Community-acquired methicillin-resistant Staphylococcus aureus: Epidemiology and potential virulence factors. Curr Infect Dis Rep 2003; 5: 459-466.
13. Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 1791.
14. Kantzanou M, Tassios PT, Tseleni-Kotsovili A et al. A multi-centre study of nosocomial methicillin-resistant Staphylococcus aureus in Greece. Int J Antimicrob Agents 1999; 12: 115-119.
15. Pantazatou A, Papaparaskevas J, Stefanou I, Papanicolas J, Demertzi E, Avlamis A. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period. Int J Antimicrob Agents 2003; 21: 542-546.
16. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003; 9: 1179-1186.
17. Mantey I, Hill RL, Foster AV, Wilson S, Wade JJ, Edmonds ME. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Commun Dis Public Health 2000; 3: 288-290.
18. Farr BM. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2004; 17: 317-322.